Correlation Between Mosaic Immunoengineerin and Biovaxys Technology
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and Biovaxys Technology Corp, you can compare the effects of market volatilities on Mosaic Immunoengineerin and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and Biovaxys Technology.
Diversification Opportunities for Mosaic Immunoengineerin and Biovaxys Technology
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mosaic and Biovaxys is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and Biovaxys Technology go up and down completely randomly.
Pair Corralation between Mosaic Immunoengineerin and Biovaxys Technology
Given the investment horizon of 90 days Mosaic Immunoengineering is expected to generate 3.55 times more return on investment than Biovaxys Technology. However, Mosaic Immunoengineerin is 3.55 times more volatile than Biovaxys Technology Corp. It trades about 0.13 of its potential returns per unit of risk. Biovaxys Technology Corp is currently generating about -0.05 per unit of risk. If you would invest 82.00 in Mosaic Immunoengineering on September 3, 2024 and sell it today you would earn a total of 18.00 from holding Mosaic Immunoengineering or generate 21.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mosaic Immunoengineering vs. Biovaxys Technology Corp
Performance |
| Timeline |
| Mosaic Immunoengineering |
| Biovaxys Technology Corp |
Mosaic Immunoengineerin and Biovaxys Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mosaic Immunoengineerin and Biovaxys Technology
The main advantage of trading using opposite Mosaic Immunoengineerin and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.| Mosaic Immunoengineerin vs. Cell Source | Mosaic Immunoengineerin vs. Marizyme | Mosaic Immunoengineerin vs. ACRO Biomedical Co |
| Biovaxys Technology vs. Biotron Limited | Biovaxys Technology vs. biOasis Technologies | Biovaxys Technology vs. Covalon Technologies | Biovaxys Technology vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |